癌抗原CA19-9 是胰腺癌,胃癌,結(jié)腸癌、直腸癌、膽囊癌的相關(guān)標(biāo)志物,大量研究證明CA19-9濃度與這些腫瘤大小有關(guān),是至今報(bào)道的對(duì)胰腺癌敏感性最高的標(biāo)志物。
CA19-9癌抗原19-9 | 貨號(hào) |
CA19-9 Cancer Antigen, Specification> 100 Ku/ml | P291-4 |
Cancer Antigen 19-9 (CA 19-9) Antigen, Native | LA055 |
Cancer Antigen 19-9 (CA 19-9) Antigen, Native,應(yīng)用:Control | LA316 |
Cancer Antigen 19-9 (CA 19-9),Highly Purified,Liquid | 151-99 |
CA 19-9 (low cross reactivity), Partially Purified | CT 3286 |
CA 19-9 (low cross reactivity), Part Purified | AU 3264 |
CA 19-9, Grade II (low cross reactivities), Part Purified | AU 3302 |
CA 19-9, Highly Purified | AU 3220 |
CA 19-9, Highly Purified | CT 3287 |
希凱生物是BBI Solutions、Medix Biochemica、Lee BioSolutions、Eastcoast Bio、Diaclone、Aalto Bio授權(quán)代理商
提供高品質(zhì)診斷試劑原料,更多產(chǎn)品信息,歡迎與我們聯(lián)系